Multifunctional neuroprotective–neurorescue drugs for Parkinson’s disease

Author： Van der Schyf Cornelis J   Geldenhuys Werner J   Youdim Moussa BH  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.2, Iss.4, 2007-07, pp. : 411-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melatonin in Parkinson's disease

By Medeiros C.  

Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. : 759-759

Springer Publishing Company

Access to resources Recommend Favorite

A vaccine for Parkinson’s disease?

By Chesselet Marie-Francoise  

Future Neurology, Vol. 1, Iss. 1, 2006-01 ,pp. : 21-23

Future Medicine

Access to resources Recommend Favorite

Pathophysiology of Parkinson’s disease

By Mandir Allen S.   Vaughan Christina  

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 270-280

Informa Healthcare

Access to resources Recommend Favorite

The Path from Anti Parkinson Drug Selegiline and Rasagiline to Multifunctional Neuroprotective Anti Alzheimer Drugs Ladostigil and M30

By  

Current Alzheimer Research, Vol. 3, Iss. 5, 2006-12 ,pp. : 541-550

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective Therapy for Parkinson's Disease

By Koller W.C.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 24-28

Elsevier

Access to resources Recommend Favorite